NAD Refers IV Drips to FDA and FTC for Claims that IV Hydration Therapy Protects Against COVID-19

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs 

301.412.7769 / press@bbbnp.org 

 

New York, NY – July 30, 2020 – The National Advertising Division (NAD), a division of BBB National Programs, has referred advertising claims made by IV Drips, Customized IV Hydration & Wellness (“IV Drips”) for its IV Hydration Therapy to the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) for review. The advertiser did not respond to NAD’s request to provide substantiation for its claims.  

Through their routine monitoring program, NAD challenged IV Drip’s Instagram post for IV Hydration Therapy, including an image with the text:  

  • “Protect Yourself & Your Loved Ones Boost Your Immune System,”  

  • Associated text stating “Trump Declares National Emergency Over COVID-19,” and  

  • “Stay Safe. Stay Healthy. Strengthen your first line of defense with an immunity Drip.”  

 

NAD determined that the immunity boosting claims, together with references to COVID-19, reasonably convey the implied message that IV Hydration Therapy protects users against COVID-19.  

NAD noted that the U.S. Centers for Disease Control and Prevention (CDC) and the FDA have both stated that there are no approved vaccines, drugs, or investigational products currently available to treat or prevent COVID-19. Both the FDA and FTC have issued dozens of warning letters to companies making claims about their products’ ability to treat or prevent COVID-19. Health and safety concerns are a top priority for NAD’s monitoring efforts, with attention currently focused on advertising for COVID-19 treatments. 

NAD was disappointed that the advertiser did not participate in the self-regulatory process, despite repeated outreach attempts. Considering the advertiser’s failure to provide a substantive response to NAD’s request for substantiation for its claims or participate in any way in the self-regulatory process, NAD has referred the matter to the FDA and FTC for possible enforcement action. 

 

### 

 

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.   

Latest Decisions

Decision

Truvani Voluntarily Discontinues Social Media Post and Two Consumer Reviews for Immune Support Following NAD Inquiry into Implied COVID-19 Messages

Following an inquiry by the National Advertising Division (NAD) of BBB National Programs, Nomolotus, LLC d/b/a Truvani discontinued a social media post for its Immune Support dietary supplement (formerly called “Under the Weather”), as well as two customer reviews...
Read more
Decision

NAD Refers IV Drips to FDA and FTC for Claims that IV Hydration Therapy Protects Against COVID-19

The National Advertising Division (NAD), a division of BBB National Programs, has referred advertising claims made by IV Drips, Customized IV Hydration & Wellness (“IV Drips”) for its IV Hydration Therapy to the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) for...
Read more
Decision

NAD Finds Certain NanoSeptic Self-Cleaning Surface Claims are Supported; Recommends Modification of Others

Following an inquiry by the National Advertising Division (NAD) initiated as part of its routine monitoring program, NAD determined that NanoTouch Materials, LLC substantiated certain express claims for its NanoSeptic surfaces...
Read more
Decision

NAD Recommends Smile Direct Club Discontinue “3x Faster to Use Than Strips” Claim for Tooth Whitening Kit; Finds Certain Other Claims as Puffery

The National Advertising Division (NAD), a division of BBB National Programs, recommended that Smile Direct Club (“SDC”) discontinue its “3x faster to use than strips” claim for its Bright On Whitening Kit. However, NAD concluded that in the absence of...
Read more